Skip to main content

Crohn's Disease

Crohn's Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

David Schwartz
Conference Coverage
10/28/2026
David A. Schwartz
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his...
10/28/2026
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
10/11/2026
Raymond Cross, MD
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
10/11/2026
Corey A. Siegel, MD, MS; Gil Y. Melmed, MD
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Bruce Sands
Expert Insights
07/19/2026
Bruce E. Sands, MD, MS
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of the DUET-CD study of combination therapy with guselkumab and golimumab in patients with Crohn's disease, which showed a significant increase in efficacy for the combination versus either drug independently.
Dr Sands reviews the results of...
07/19/2026
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Research Review
05/13/2026
Miguel D. Regueiro, MD
Dr Regueiro reviews his presentation from Digestive Disease Week on the treatment of perianal Crohn's disease, including advances in medical therapies and surgical approaches. 
Dr Regueiro reviews his presentation from Digestive Disease Week on the treatment of perianal Crohn's disease, including advances in medical therapies and surgical approaches. 
Dr Regueiro reviews his...
05/13/2026
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Conference Coverage
05/06/2026
Edward L. Barnes, MD
Dr Barnes reviewed his presentation of results from the VIVID 1 and VIVID 2 trials of mirkizumab in patients with Crohn's disease with exposure to anti-TNF therapy, which found that 65% of those in endoscopic response at week 52 maintained...
Dr Barnes reviewed his presentation of results from the VIVID 1 and VIVID 2 trials of mirkizumab in patients with Crohn's disease with exposure to anti-TNF therapy, which found that 65% of those in endoscopic response at week 52 maintained...
Dr Barnes reviewed his...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Christina Ha
Conference Coverage
12/16/2025
Christina Ha, MD
Dr Christina Ha reinforced the progressive nature of CD and the need for objective, individualized decision-making across disease stages.
Dr Christina Ha reinforced the progressive nature of CD and the need for objective, individualized decision-making across disease stages.
Dr Christina Ha reinforced the...
12/16/2025
Advances in Inflammatory Bowel Disease Network
Conference Coverage
12/09/2025
Marla C. Dubinsky, MD
Dr Dubinsky told attendees at the Advances in IBD annual meeting that the time of diagnosis is a "golden moment" for the patient with newly diagnosed Crohn's disease.
Dr Dubinsky told attendees at the Advances in IBD annual meeting that the time of diagnosis is a "golden moment" for the patient with newly diagnosed Crohn's disease.
Dr Dubinsky told attendees at...
12/09/2025
Advances in Inflammatory Bowel Disease Network
Laura Raffals
Conference Coverage
12/09/2025
Laura Raffals
Dr Raffals explains a framework for choosing a second therapy for the patient with Crohn's disease who did not respond, or lost response, to the first therapy.
Dr Raffals explains a framework for choosing a second therapy for the patient with Crohn's disease who did not respond, or lost response, to the first therapy.
Dr Raffals explains a framework...
12/09/2025
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
12/09/2025
Miguel D. Regueiro, MD
Dr Regueiro provides updates on the care--and possible prevention of recurrence—of Crohn's disease following surgery, from his presentation at the 2025 AIBD Annual Meeting in Orlando, Florida.
Dr Regueiro provides updates on the care--and possible prevention of recurrence—of Crohn's disease following surgery, from his presentation at the 2025 AIBD Annual Meeting in Orlando, Florida.
Dr Regueiro provides updates on...
12/09/2025
Advances in Inflammatory Bowel Disease Network